Early and late stroke after mitral valve replacement with a mechanical prosthesis: risk factor analysis of a 24-year experience

J Thorac Cardiovasc Surg. 2003 Aug;126(2):358-64. doi: 10.1016/s0022-5223(03)00550-6.

Abstract

Objective: We evaluated risk factors for mortality and stroke after mechanical mitral valve replacement between May 1977 and December 2001.

Methods: Early and late mortality and stroke were assessed. Potential predictors of mortality and stroke were entered into a Cox proportional hazards model. Actuarial survival and freedom from stroke were determined by a log-rank test.

Results: Mitral valve replacement was performed in 812 patients. Concomitant procedures included left atrial appendage closure in 493 (61%) patients, tricuspid annuloplasty-replacement in 348 (43%) patients, maze procedure in 185 (23%) patients, plication of the left atrium in 148 (18%) patients, and other procedures in 151 (19%) patients. Five-year actuarial survival was 91.1% +/- 2.3%. Freedom from stroke at 8 years was significantly better in patients with sinus rhythm versus atrial fibrillation (P <.001). Ninety-nine percent of patients with mitral valve replacement combined with a maze procedure were free from stroke, whereas only 89% of patients with mitral valve replacement alone were free from stroke at 8 years after surgical intervention. Seventy-two patients had late stroke; sixty-five patients (90%) were in atrial fibrillation, and 47 (65%) patients had the left atrial appendage closed. Multivariate analysis showed that late atrial fibrillation (odds ratio, 3.39; 95% confidence interval, 1.72-6.67; P =.0001) and omission of the maze procedure (odds ratio, 3.40; 95% confidence interval, 1.14-10.14; P =.003) were the significant risk factors for late stroke.

Conclusions: Persistent atrial fibrillation was the most significant risk factor for late stroke after mechanical mitral valve replacement. Restoration of sinus rhythm with a maze procedure nearly eliminated the risk of late stroke, whereas neither closure of the left atrial appendage nor therapeutic anticoagulation prevented this complication.

Publication types

  • Comparative Study
  • Evaluation Study

MeSH terms

  • Adolescent
  • Adrenergic beta-Antagonists / therapeutic use
  • Adult
  • Aged
  • Anti-Arrhythmia Agents / therapeutic use
  • Atrial Fibrillation / drug therapy
  • Atrial Fibrillation / epidemiology
  • Atrial Fibrillation / etiology
  • Female
  • Follow-Up Studies
  • Heart Valve Diseases / epidemiology
  • Heart Valve Diseases / physiopathology
  • Heart Valve Diseases / therapy*
  • Heart Valve Prosthesis Implantation / instrumentation*
  • Heart Valve Prosthesis*
  • Hospital Mortality
  • Humans
  • Incidence
  • Japan / epidemiology
  • Male
  • Middle Aged
  • Mitral Valve / pathology*
  • Mitral Valve / physiopathology
  • Mitral Valve / surgery*
  • Morbidity
  • Multivariate Analysis
  • Postoperative Complications / drug therapy
  • Postoperative Complications / etiology*
  • Postoperative Complications / mortality
  • Postoperative Hemorrhage / epidemiology
  • Postoperative Hemorrhage / etiology
  • Predictive Value of Tests
  • Recurrence
  • Retrospective Studies
  • Risk Factors
  • Severity of Illness Index
  • Stroke / drug therapy
  • Stroke / epidemiology
  • Stroke / etiology*
  • Survival Analysis
  • Time Factors
  • Treatment Outcome

Substances

  • Adrenergic beta-Antagonists
  • Anti-Arrhythmia Agents